Brief: Caris Life Sciences Adds Breast Cancer Signature For Capecitabine To Ai Insights
24/02/2026 13:31
Feb 24 (Reuters) - Caris Life Sciences Inc CAI.O: CARIS LIFE SCIENCES INC - ADDS BREAST CANCER SIGNATURE FOR CAPECITABINE TO AI INSIGHTS Source text: ID:nPn2r4bf8a Further company coverage: CAI.O (((( Reuters.briefs@thomsonreuters.com ;));))
Recent news on Caris Life Sciences
See all newsUS RESEARCH ROUNDUP-Analog Devices, IBM, Qualcomm
Caris Life Sciences, Inc. reports results for the quarter ended June 30 - Earnings Summary
Caris Life Sciences Q2 revenue rises 45% on the back of molecular profiling services
Caris Life Sciences Inc expected to post earnings of 1 cent a share - Earnings Preview
Caris Life Sciences Q1 revenue rises on demand for molecular profiling services